Trials / Completed
CompletedNCT05375942
This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry
Characteristics and 6-month Outcomes Among Real-World Rheumatoid Arthritis Patients Initiating Inflectra
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 255 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a retrospective observational study looking at the characteristics and outcomes of participants taking Inflectra using the CorEvitas Rheumatoid Arthritis Registry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inflectra | 1\. To describe the characteristics of patients newly initiated on Inflectra. |
| DRUG | Inflectra | 2\. To describe 6-month outcomes after initiating Inflectra, among patients who have 6 months follow-up information in the CorEvitas' RA Registry. |
Timeline
- Start date
- 2022-11-11
- Primary completion
- 2022-11-11
- Completion
- 2022-11-11
- First posted
- 2022-05-17
- Last updated
- 2024-04-12
- Results posted
- 2024-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05375942. Inclusion in this directory is not an endorsement.